Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration
NCT02226666
·
clinicaltrials.gov ↗
COMPLETED
Status
107
Enrollment
OTHER
Sponsor class
Conditions
Liver Tumor
Interventions
DRUG:
MRI with Multihance
DRUG:
MRI with Eovist
Sponsor
University of Michigan